Identification Generic Name (2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol DrugBank Accession Number DB04776 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol (DB04776) ×  Close Weight Average: 368.4759  Monoisotopic: 368.232459548  Chemical Formula C 20 H 28 N 6 O Synonyms (2R)-2-({6-[Benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-1-butanol Aftin-4 Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Pyridoxal kinase Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Heterocyclic Compounds, Fused-Ring 
 Purines Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as 6-alkylaminopurines. These are compounds that contain an alkylamine group attached at the 6-position of a purine. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Imidazopyrimidines Sub Class Purines and purine derivatives Direct Parent 6-alkylaminopurines Alternative Parents Dialkylarylamines  /  Benzylamines  /  Secondary alkylarylamines  /  Aminopyrimidines and derivatives  /  N-substituted imidazoles  /  Imidolactams  /  Heteroaromatic compounds  /  Azacyclic compounds  /  Primary alcohols  /  Organopnictogen compounds  /  Hydrocarbon derivatives 
 
 
  show 1 more Substituents 6-alkylaminopurine  /  Alcohol  /  Amine  /  Aminopyrimidine  /  Aromatic heteropolycyclic compound  /  Azacycle  /  Azole  /  Benzenoid  /  Benzylamine  /  Dialkylarylamine  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Imidazole  /  Imidolactam  /  Monocyclic benzene moiety  /  N-substituted imidazole  /  Organic nitrogen compound  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Primary alcohol  /  Pyrimidine  /  Secondary aliphatic/aromatic amine  /  Secondary amine 
 
 
  show 15 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key YPYWONAECUVKHY-MRXNPFEDSA-N InChI InChI=1S/C20H28N6O/c1-5-16(12-27)22-20-23-18(25(4)11-15-9-7-6-8-10-15)17-19(24-20)26(13-21-17)14(2)3/h6-10,13-14,16,27H,5,11-12H2,1-4H3,(H,22,23,24)/t16-/m1/s1 IUPAC Name (2R)-2-({6-[benzyl(methyl)amino]-9-(propan-2-yl)-9H-purin-2-yl}amino)butan-1-ol SMILES [H][C@@](CC)(CO)NC1=NC2=C(N=CN2C(C)C)C(=N1)N(C)CC1=CC=CC=C1 References General References Not Available External Links PubChem Compound 5289296 PubChem Substance 46506238 ChemSpider 4451290 BindingDB 10909 ChEMBL CHEMBL1235702 ZINC ZINC000012504508 PDBe Ligand RMC PDB Entries 1ygj Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.24 mg/mL ALOGPS logP 3.45 ALOGPS logP 3.53 Chemaxon logS -3.2 ALOGPS pKa (Strongest Acidic) 14.32 Chemaxon pKa (Strongest Basic) 5.06 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 6 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 79.1 Å 2 Chemaxon Rotatable Bond Count 8 Chemaxon Refractivity 110.38 m 3 ·mol -1 Chemaxon Polarizability 42.15 Å 3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 1.0 Blood Brain Barrier - 0.5345 Caco-2 permeable - 0.5799 P-glycoprotein substrate Substrate 0.8705 P-glycoprotein inhibitor I Non-inhibitor 0.8153 P-glycoprotein inhibitor II Non-inhibitor 0.9217 Renal organic cation transporter Non-inhibitor 0.7503 CYP450 2C9 substrate Non-substrate 0.8463 CYP450 2D6 substrate Non-substrate 0.7628 CYP450 3A4 substrate Non-substrate 0.5059 CYP450 1A2 substrate Inhibitor 0.77 CYP450 2C9 inhibitor Inhibitor 0.5665 CYP450 2D6 inhibitor Inhibitor 0.7374 CYP450 2C19 inhibitor Non-inhibitor 0.9045 CYP450 3A4 inhibitor Non-inhibitor 0.7282 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9172 Ames test Non AMES toxic 0.5774 Carcinogenicity Non-carcinogens 0.8847 Biodegradation Not ready biodegradable 0.9727 Rat acute toxicity 2.7053 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.7587 hERG inhibition (predictor II) Non-inhibitor 0.5529    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Pyridoxal kinase Kind Protein Organism Humans Pharmacological action Unknown General Function Zinc ion binding Specific Function Required for synthesis of pyridoxal-5-phosphate from vitamin B6. Gene Name PDXK Uniprot ID O00764 Uniprot Name Pyridoxal kinase Molecular Weight 35102.105 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 11, 2007 17:49 / Updated at June 12, 2020 16:52 